Ronald van Vollenhoven

Ronald van Vollenhoven

UNVERIFIED PROFILE

Are you Ronald van Vollenhoven?   Register this Author

Register author
Ronald van Vollenhoven

Ronald van Vollenhoven

Publications by authors named "Ronald van Vollenhoven"

Are you Ronald van Vollenhoven?   Register this Author

100Publications

3116Reads

30Profile Views

Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial.

J Rheumatol 2019 Jun 1;46(6):555-563. Epub 2019 Feb 1.

From the Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Crescendo Bioscience, South San Francisco, California, USA; Section of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Institute of Environmental Medicine (IMM), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180537
Publisher Site
http://dx.doi.org/10.3899/jrheum.180537DOI Listing
June 2019

Methotrexate for Prevention of Cardiovascular Events.

N Engl J Med 2019 06;380(23):2276-2277

Amsterdam University Medical Centers, Amsterdam, the Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1905061DOI Listing
June 2019

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis.

Joint Bone Spine 2019 May 15;86(3):363-368. Epub 2018 Nov 15.

Service de rhumatologie, centre de référence des maladies autoimmunes systemiques rares Est Sud-Ouest (RESO), hôpital de Hautepierre, 1, avenue Molière BP 83049, 67098 Strasbourg cedex, France; Inserm UMR-S1109, 67098 Strasbourg cedex, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S1297319X183030
Publisher Site
http://dx.doi.org/10.1016/j.jbspin.2018.11.001DOI Listing
May 2019

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

The relationship between remission and health-related quality of life in a cohort of SLE patients.

Rheumatology (Oxford) 2019 Apr;58(4):628-635

Department of Rheumatology, Amsterdam Rheumatology and immunology Center, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article/58/4/628/52308
Publisher Site
http://dx.doi.org/10.1093/rheumatology/key349DOI Listing
April 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis.

Front Immunol 2019 24;10:902. Epub 2019 Apr 24.

Amsterdam UMC, Vrije Universiteit Amsterdam, Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491736PMC
April 2019

Assessing joint inflammation-a way forward for SLE trials?

Rheumatology (Oxford) 2019 Apr 9. Epub 2019 Apr 9.

Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez131DOI Listing
April 2019

Treat-to-target in rheumatoid arthritis - are we there yet?

Nat Rev Rheumatol 2019 Mar;15(3):180-186

Amsterdam University Medical Centers, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41584-019-0170-5
Publisher Site
http://dx.doi.org/10.1038/s41584-019-0170-5DOI Listing
March 2019

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.

Sci Transl Med 2019 Jan;11(477)

Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, Netherlands, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.aa
Publisher Site
http://dx.doi.org/10.1126/scitranslmed.aat3356DOI Listing
January 2019

Joint Mobilization of the Hands of Patients With Rheumatoid Arthritis: Results From an Assessor-Blinded, Randomized Crossover Trial.

J Manipulative Physiol Ther 2019 Jan 14;42(1):34-46. Epub 2019 Mar 14.

Musculoskeletal & Sports Injury Epidemiology Center, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmpt.2018.04.007DOI Listing
January 2019

Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies.

Expert Opin Biol Ther 2018 Dec 20. Epub 2018 Dec 20.

a Division of Rheumatology, Department of Medicine , Karolinska Institutet , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2019.1561856DOI Listing
December 2018

Evolution of clinical trials for rheumatoid arthritis and spondyloarthritis.

Curr Opin Rheumatol 2018 07;30(4):340-346

Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0000000000000516DOI Listing
July 2018

Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort.

Int J Rheumatol 2018 11;2018:9152480. Epub 2018 Jun 11.

Eugeniahemmet, T2, Karolinska Universitetssjukhuset, Solna, 17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/9152480DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016163PMC
June 2018

Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.

Clin Exp Rheumatol 2018 Jan-Feb;36(1):21-28. Epub 2017 Jun 5.

Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
April 2018

Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Nat Rev Rheumatol 2018 Jan;14(2):75-93

GENYO Centre for Genomics and Oncological Research: Pfizer - University of Granada - Andalusian Government, Avenida de la Ilustración 114, P.T.S., 18016 Granada, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2017.220DOI Listing
January 2018

The effects of an educational meeting and subsequent computer reminders on the ordering of laboratory tests by rheumatologists: an interrupted time series analysis.

Clin Exp Rheumatol 2017 May-Jun;35(3):379-383. Epub 2017 Mar 23.

Department of Rheumatology and Laboratory, Sint Maartenskliniek, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
August 2017

Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.

Clin Exp Rheumatol 2016 Nov-Dec;34(6):1065-1071. Epub 2016 Aug 31.

Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital; and School of Medicine, University of Tampere, Finland.

View Article

Download full-text PDF

Source
June 2017

Fully automated joint space width measurement and digital X-ray radiogrammetry in early RA.

RMD Open 2017 29;3(1):e000369. Epub 2017 Jun 29.

Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2016-000369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574453PMC
June 2017

Editorial: Who Gets Lupus? Clues to a Tantalizing Syndrome.

Arthritis Rheumatol 2017 03;69(3):483-486

Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40005DOI Listing
March 2017

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration.

J Rheumatol 2017 02 15;44(2):162-169. Epub 2017 Jan 15.

From the Karolinska Institute, Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Stockholm, Sweden; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; ARBITER, Institute of Rheumatology, Moscow, Russia; DANBIO, Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark; Institute of Rheumatology, Prague, Czech Republic; Swiss Clinical Quality Management (SCQM) Registry, University Hospital of Geneva, Geneva; SCQM Foundation, Zurich, Switzerland; National Register for Biologic Treatment in Finland (ROB-FIN), Helsinki University Central Hospital, Helsinki, Finland; Reuma.pt Registry, Instituto de Medicina Molecular da Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; BioRx.si University Medical Centre, Ljubljana, Ljubljana, Slovenia; Rheumatology Department, Hospital Clinic of Barcelona, Barcelona; Hospital Clinico Universidad De Santiago, Santiago, Spain; Cantacuzino Hospital, Bucharest, Romania.

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/jrheum/early/2017/01/05/jrheum
Web Search
http://dx.doi.org/10.3899/jrheum.160460DOI Listing
February 2017

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.

Lupus Sci Med 2017 8;4(1):e000192. Epub 2017 Feb 8.

Division of Rheumatology , School of Medicine, Johns Hopkins University , Baltimore, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2016-000192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307372PMC
February 2017

Complex disease=complex trial? Lessons from a successful trial of anti-IFNα in SLE.

Ann Rheum Dis 2016 11 21;75(11):1899-1901. Epub 2016 Jun 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-209345DOI Listing
November 2016

Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials.

RMD Open 2016 6;2(2):e000323. Epub 2016 Sep 6.

Department of Medicine, ClinTRID, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Immunology & Rheumatology, Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2016-000323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013458PMC
September 2016

Prevalence and comorbidity of relapsing polychondritis.

Clin Epidemiol 2016 30;8:361-362. Epub 2016 Sep 30.

Department of Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CLEP.S121272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053386PMC
September 2016

New therapeutic approaches in rheumatoid arthritis.

Presse Med 2016 Jun 27;45(6 Pt 2):e179-92. Epub 2016 May 27.

Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00, Karolinska Universitetssjukhustet 171 76, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2016.05.004DOI Listing
June 2016

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.

RMD Open 2016 10;2(1):e000213. Epub 2016 May 10.

Karolinska Institute, Stockholm, Sweden; Amsterdam Rheumatology and Immunology Center ARC Academic Medical Center, Amsterdam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2015-000213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874056PMC
June 2016

Systemic lupus erythematosus.

Nat Rev Dis Primers 2016 06 16;2:16039. Epub 2016 Jun 16.

The London Lupus Centre, London Bridge Hospital, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrdp201639
Publisher Site
http://dx.doi.org/10.1038/nrdp.2016.39DOI Listing
June 2016